MedTrace Logo

Trisomy of Chromosome 21 Diagnosis by High Output Sequencing

NCT01118507 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 976

Last updated 2026-01-15

No results posted yet for this study

Summary

Demonstrate that the High output shotgun sequencing of the foetal DNA in the maternal blood could allow a complete discrimination between the mothers of a trisomic fetus 21 or a DISOMIQUE foetus 21 from the first quarter of the pregnancy, and so to obtain a reliable alternative in invasive procedure.

Conditions

  • Trisomy 21 - Translocation

Sponsors & Collaborators

  • URC-CIC Paris Descartes Necker Cochin

    collaborator OTHER

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • LAURENT SALOMON, MCU PH · APHP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-03-31
Primary Completion
2013-09-30
Completion
2013-10-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01118507 on ClinicalTrials.gov